80 related articles for article (PubMed ID: 1300912)
21. [Are rheological markers of poor prognosis present in diabetic arteriopathies?].
Boisseau MR
J Mal Vasc; 2001 Apr; 26(2):117-21. PubMed ID: 11319417
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
23. [The physiopathological basis for hemorrheological changes in diabetes].
Neri Serneri GG; Galanti G; Paoli G
Ric Clin Lab; 1983; 13 Suppl 3():149-57. PubMed ID: 6369493
[TBL] [Abstract][Full Text] [Related]
24. [Obesity and diabetes in the aged--correlation and relation to some chronic diseases].
Weber P; Dedek I; Kocourková B
Z Gerontol; 1993; 26(4):280-4. PubMed ID: 8212799
[TBL] [Abstract][Full Text] [Related]
25. [Serum level of sL-selectin and leukocyte surface expression of L-selectin in patients with type 2 diabetes].
Mastej K; Adamiec R
Przegl Lek; 2011; 68(3):140-5. PubMed ID: 21812228
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
[TBL] [Abstract][Full Text] [Related]
28. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.
Chiodini I; Adda G; Scillitani A; Coletti F; Morelli V; Di Lembo S; Epaminonda P; Masserini B; Beck-Peccoz P; Orsi E; Ambrosi B; Arosio M
Diabetes Care; 2007 Jan; 30(1):83-8. PubMed ID: 17192338
[TBL] [Abstract][Full Text] [Related]
29. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
30. Deformability and filterability of white blood cell subpopulations. Evaluation of these parameters in the cell line HL-60 and in type II diabetes mellitus.
Athanassiou G; Matsouka P; Kaleridis V; Missirlis Y
Clin Hemorheol Microcirc; 2000; 22(1):35-43. PubMed ID: 10711820
[TBL] [Abstract][Full Text] [Related]
31. Diabetic hypertension--the importance of fibrinogen and blood viscosity.
Feher MD; Rampling MW; Sever PS; Elkeles RS
J Hum Hypertens; 1988 Aug; 2(2):117-22. PubMed ID: 3244146
[TBL] [Abstract][Full Text] [Related]
32. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus.
Tsai JC; Sheu SH; Chiu HC; Chung FM; Chang DM; Chen MP; Shin SJ; Lee YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):111-8. PubMed ID: 16703635
[TBL] [Abstract][Full Text] [Related]
33. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
34. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
[TBL] [Abstract][Full Text] [Related]
35. [Blood rheology abnormalities in diabetes mellitus].
Le Devehat C
J Mal Vasc; 1989; 14(1):64-7. PubMed ID: 2646390
[TBL] [Abstract][Full Text] [Related]
36. Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications.
Caimi G; Montana M; Ferrara F; Porretto F; Musso M; Canino B; Lo Presti R
Acta Diabetol; 2003 Mar; 40(1):14-9. PubMed ID: 12682824
[TBL] [Abstract][Full Text] [Related]
37. [Thyroid function study in patients with diabetes mellitus].
Muñoz Núñez A; González Sarmiento E; Ergueta Martín P; Escorial Miguel C; Crespo Pinilla J; Marañón Cabello A
An Med Interna; 1990 Jun; 7(6):291-3. PubMed ID: 2102733
[TBL] [Abstract][Full Text] [Related]
38. Role of leukocytes in diabetic microcirculatory disturbances.
Miyamoto K; Ogura Y; Kenmochi S; Honda Y
Microvasc Res; 1997 Jul; 54(1):43-8. PubMed ID: 9245643
[TBL] [Abstract][Full Text] [Related]
39. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
40. Rheological properties of white blood cells are changed in diabetic patients with microvascular complications.
Vermes I; Steinmetz ET; Zeyen LJ; van der Veen EA
Diabetologia; 1987 Jun; 30(6):434-6. PubMed ID: 3678663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
